Periosteal Osteosarcoma: A Single-Institutional Study of Factors Related to Oncologic Outcomes.
Chung Ming ChanAdam D LindsayAndre R V SpiguelParker C GibbsMark T ScarboroughPublished in: Sarcoma (2018)
These findings add to the available evidence which has failed to find any survival benefit from chemotherapy; patients with this rare disease and their families should be counselled regarding the unclear role of chemotherapy in this rare subtype of osteosarcoma.